MedTrace Logo

Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain

NCT02084511 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-04-12

Study results available
· View outcomes & findings →

Summary

To investigate the effectiveness of BI 1026706 powder for reconstitution of an oral solution compared to placebo and the relative effectiveness compared to Celecoxib.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Placebo to BI 1026706 solution

Placebo to BI 1026706 solution

DRUG

BI 1026706

BI 1026706

DRUG

Placebo to BI 1026706 tablet

Placebo to BI 1026706 tablet

DRUG

Celecoxib

Celecoxib capsule

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02084511 on ClinicalTrials.gov